Daily closing price · 250 sessions
Quantitative price outlook based on available market signals. Not financial advice.
Indicators calculated from the stored daily price history.
A verified, data-driven analysis will be generated here from price action, technical indicators, fundamentals, earnings and market context.
Dedicated research sections for 2026, 2030, 2035, 2040 and 2050. Numerical targets will appear only after the long-horizon model is validated.
Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2026 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2030 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2035 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2040 research →Research inputs: earnings, revenue growth, valuation, technical regime, volatility, sector context and market conditions.
Read 2050 research →Only stories explicitly associated with this stock are shown.
IDHQ is a smart beta ETF with $1.05 billion in assets that tracks high-quality international developed market stocks. It offers low expenses at 0.29%, strong year-to-date performance of 25.91%, and a low-risk profile with a beta of 0.92. The fund holds 213 stocks with top holdings including Roche, ASML, and Novartis.
ASML rose 1% to $1,590.97 in the latest session, outperforming broader market indices. Despite a 16.35% decline over the past month, the semiconductor equipment supplier maintains a Zacks Rank #2 (Buy) rating. Upcoming Q3 earnings on October 14, 2026 are projected to show 96.41% EPS growth and 49.99% revenue growth year-over-year. The stock trades at a Forward P/E of 35.03, above its industry average of 28.87, but maintains a PEG ratio of 0.78, in line with industry peers.
ASML holds a strong average brokerage recommendation (ABR) of 1.29 with 23 Strong Buy ratings from 28 firms. However, the article cautions that brokerage recommendations often carry positive bias due to institutional vested interests. The company received a Zacks Rank #2 (Buy) rating based on earnings estimate revisions, with consensus estimates increasing 0.3% over the past month to $44.97, suggesting analyst optimism about near-term price movements.
ASML stock fell 6.2% on September 14, 2026, after AI executives including Anthropic CEO Dario Amodei called for slowing the development of advanced AI models. Since ASML manufactures chip-making equipment essential for AI processors, slower AI development could reduce demand for their systems. However, the article suggests the market reaction may be overblown.
The article compares two semiconductor equipment giants: Applied Materials, which provides diverse chip fabrication tools, and ASML, which dominates extreme ultraviolet (EUV) lithography. ASML is recommended as the better buy despite higher valuation, citing its monopoly in advanced chip manufacturing technology and superior financial metrics, while Applied Materials faces geopolitical risks and lacks comparable competitive moats.
Common questions about price, predictions, long-term forecasts, technicals and research methodology.
ASML is currently shown at $1,602.22 in the latest stored market quote. The page is refreshed from the connected market-data pipeline.
A quantitative forecast is not currently available for ASML.
The 2026 long-term forecast section is included as a research framework. A numerical 2026 target is shown only after a dedicated long-horizon model has produced and validated it; the current 24H–90D model is not presented as a 2026 target.
The 2030 section tracks the inputs that a validated long-horizon model should use, including company growth, valuation, earnings, market regime and sector conditions. No unsupported price target is displayed.
The 2035, 2040 and 2050 sections are reserved for long-term model outputs. US Market AI does not invent numerical targets when validated long-horizon data is unavailable.
The page can display RSI, MACD, SMA 50, SMA 200, EMA 20, ATR, ADX, volatility, Bollinger levels, stochastic, support and resistance from stored daily price history.
Fundamental data is not currently populated for this stock, so the page does not estimate or fabricate missing values.
The latest ticker-linked news appears in the Market News section of this page. Stories are shown with source, publication date and sentiment when available.
There is not yet enough mature evaluation data on this page to claim a verified accuracy rate.
No. US Market AI provides research and model estimates for informational purposes. Forecasts can be wrong and should not be treated as personalized financial advice.
US Market AI combines quantitative signals and verified market data to support research. Forecasts are estimates, can be wrong, and are not financial advice.